Stocks Comparison
Boston Scientific vs Medline: revenue, profit, margins and growth compared
Boston Scientific brought in $20.1B of revenue in fiscal 2025, Medline $28.4B in fiscal 2025. Boston Scientific kept 14.4% of its revenue as net profit, Medline 4.1%. Free cash flow was $3.7B at Boston Scientific and $1.3B at Medline.
Side by side, latest fiscal year
| BSX | MDLN | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $20.1B | $28.4B |
| Revenue growth | +19.9% | n/a |
| Net income | $2.9B | $1.2B |
| Net margin | 14.4% | 4.1% |
| Free cash flow | $3.7B | $1.3B |
| Free cash flow margin | 18.2% | 4.6% |
| Earnings per share (diluted) | $1.94 | -$0.01 |
| Cash | $2B | $1.9B |
| Debt | $11.1B | $12.6B |
| Price to earnings | 22.6 | n/a |
| Market value | $63.7B | $45.6B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #30 of 523 · Health care | #23 of 523 · Health care |
Over the years
BSX $20.1BMDLN $28.4B
BSX $2.9BMDLN $1.2B
BSX 14.4%MDLN 4.1%
BSX +19.9%MDLN +9.8%
BSX $3.7BMDLN $1.3B
Questions about Boston Scientific and Medline
Which is bigger by revenue, Boston Scientific or Medline?
Medline is bigger by revenue: $28.4B in fiscal 2025, against $20.1B for Boston Scientific in fiscal 2025.
Which keeps more of its revenue as profit, Boston Scientific or Medline?
Boston Scientific had a net margin of 14.4% in fiscal 2025; Medline had 4.1% in fiscal 2025.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.